Publications

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis

Kelly M. et al, (2020), Amyotrophic lateral sclerosis & frontotemporal degeneration

Ellul M. et al, (2020), Journal of Neurology, Neurosurgery and Psychiatry

TURNER M. and Al-Chalabi A., (2020), Journal of Neurology, Neurosurgery and Psychiatry

Joilin G. et al, (2020), Brain Communications

Shefner J. et al, (2020), Clinical Neurophysiology

Turner MR. and Talbot K., (2020), Pract Neurol

GABEL M. et al, (2020), Annals of Clinical and Translational Neurology

Salerno F. et al, (2020), Trends in Immunology, 41, 240 - 254

Swash M. et al, (2020), J Neurol Neurosurg Psychiatry, 91, 227 - 234

Koplin JJ. et al, (2020), Ethics Hum Res, 42, 2 - 12

Tu S. et al, (2020), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 7

Monzón-Casanova E. et al, (2020), eLife, 9

Turner MR. et al, (2020), J Neurol Neurosurg Psychiatry

Garcia-Gancedo L. et al, (2019), JMIR Mhealth Uhealth, 7

Robertson J. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E22 - E23

Edmond EC. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E72 - E72

Thompson AG. and Turner MR., (2019), J Neurol Neurosurg Psychiatry, 90, 1303 - 1304

Kiernan MC., (2019), J Neurol Neurosurg Psychiatry, 90

Turner MR., (2019), J Neurol Neurosurg Psychiatry, 90, 1190 - 1191

Johnston JM. et al, (2019), Science Advances, 5